Duanqing Pei Selected Research

Duanqing Pei Research Topics

Disease

35	Neoplasms (Cancer) 03/2022 - 02/2002
8	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2002
4	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2018
3	Hematologic Neoplasms (Hematological Malignancy) 03/2022 - 01/2019
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2017
3	Genomic Instability 01/2022 - 07/2005
3	COVID-19 12/2021 - 01/2020
3	Teratoma (Teratoid Tumor) 12/2021 - 06/2009
3	Inborn Genetic Diseases (Disease, Hereditary) 05/2015 - 04/2011
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 10/2017
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2019
2	Thalassemia 05/2015 - 11/2013
2	Laminopathies 04/2011 - 07/2005
2	Prostatic Neoplasms (Prostate Cancer) 05/2009 - 03/2004
2	Pathologic Processes 05/2009 - 03/2004
1	Virus Diseases (Viral Diseases) 11/2023
1	Brain Diseases (Brain Disorder) 01/2023
1	Wounds and Injuries (Trauma) 11/2022
1	Acute Kidney Injury (Acute Renal Failure) 11/2022
1	Hemophilia B (Haemophilia B) 11/2022
1	Inflammation (Inflammations) 01/2022
1	Eye Diseases (Eye Disease) 01/2022
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Carcinogenesis 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Myocardial Infarction 01/2022
1	Multiple Myeloma 01/2022
1	Animal Disease Models 12/2021
1	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2021
1	Cytokine Release Syndrome 01/2021
1	B-Cell Leukemia (Leukemia, B Cell) 01/2021
1	Fever (Fevers) 09/2020
1	Starvation 10/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Mesothelioma 01/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 10/2017
1	Philadelphia Chromosome 10/2017
1	Adenocarcinoma of Lung 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017

Drug/Important Bio-Agent (IBA)

10	Matrix Metalloproteinases (MMPs)IBA 01/2010 - 02/2002
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2002
7	Chimeric Antigen ReceptorsIBA 03/2022 - 01/2016
6	Matrix Metalloproteinase 14 (MT1-MMP)IBA 11/2010 - 03/2002
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2005
2	Chloroquine (Aralen)FDA LinkGeneric 09/2020 - 01/2020
2	AntigensIBA 01/2020 - 01/2017
2	VaccinesIBA 01/2020 - 01/2020
2	Sorting NexinsIBA 10/2019 - 12/2014
2	Insulin (Novolin)FDA Link 01/2019 - 01/2017
2	Alkaline PhosphataseIBA 10/2015 - 06/2009
2	Phosphotransferases (Kinase)IBA 03/2012 - 12/2010
2	Lamin Type A (Lamin A)IBA 04/2011 - 07/2005
2	EndopeptidasesIBA 05/2009 - 02/2002
2	Metalloproteases (Metalloproteinases)IBA 09/2006 - 01/2004
2	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 12/2004 - 03/2004
2	Collagen Type I (Type I Collagen)IBA 12/2004 - 01/2004
1	InterferonsIBA 11/2023
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2023
1	NeuropeptidesIBA 01/2023
1	gamma-Aminobutyric Acid (GABA)IBA 01/2023
1	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 01/2023
1	Lipid PeroxidesIBA 11/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2022
1	3' Untranslated Regions (3' UTR)IBA 11/2022
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 11/2022
1	Ophthalmic Solutions (Eye Drops)IBA 01/2022
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022
1	RecQ HelicasesIBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 12/2021
1	InterleukinsIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	ChemokinesIBA 01/2021
1	Viral RNAIBA 09/2020
1	Cancer VaccinesIBA 01/2020
1	Vaccine AdjuvantsIBA 01/2020
1	Granzymes (Granzyme)IBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	CytokinesIBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019
1	MesothelinIBA 01/2019
1	AntibodiesIBA 11/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	bcr-abl Fusion ProteinsIBA 10/2017
1	src-Family KinasesIBA 10/2017
1	olverembatinibIBA 10/2017
1	Polycomb Repressive Complex 2IBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017

Therapy/Procedure

11	Therapeutics 01/2022 - 12/2004
5	Immunotherapy 03/2022 - 01/2017
3	Transplantation 12/2021 - 08/2011
1	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2022